Nektar Therapeutics reported $733.46M in Current Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Agios Pharmaceuticals AGIO:US $ 975.14M 89.09M
ALKERMES ALKS:US 1.01B 47.34M
Amgen AMGN:US $ 18520M 865M
Astrazeneca AZN:US 22.65B 3.6B
Baxter International BAX:US $ 8173M 699M
Biocryst Pharmaceuticals BCRX:US $ 511.71M 54.42M
Biogen BIIB:US $ 7915.9M 59.4M
Bluebird Bio BLUE:US $ 254.92M 81.6M
Bristol Myers Squibb BMY:US $ 30121M 3141M
Cara Therapeutics CARA:US $ 151.76M 21.53M
Eisai 4523:JP Y 640606M 53549M
Eli Lilly And LLY:US $ 16964.7M 1487.7M
Esperion Therapeutics ESPR:US $ 290.82M 38.15M
Exelixis EXEL:US $ 1842.74M 8M
Gilead Sciences GILD:US $ 12629M 2143M
GlaxoSmithKline GSK:LN 28.99B 10.31B
Halozyme Therapeutics HALO:US $ 988.69M 62.4M
Immunogen IMGN:US $ 456.72M 43.28M
IONIS PHARMACEUT IONS:US $ 2253.12M 91.92M
Ironwood Pharmaceuticals IRWD:US $ 710.1M 35.12M
Karyopharm Therapeutics KPTI:US $ 276.53M 927K
Macrogenics MGNX:US $ 218.2M 61.36M
Merk MRK:US $ 31184M 918M
Mirati Therapeutics MRTX:US $ 1343.12M 164.87M
Nektar Therapeutics NKTR:US $ 733.46M 62.13M
Novartis NOVN:VX 37.24B 8.48B
Sarepta Therapeutics SRPT:US $ 2530.95M 73.15M
Seattle Genetics SGEN:US $ 2771.26M 97.94M
Takeda 4502:JP Y 2593642M 115749M
Teva Pharmaceutical TEVA:IT 12.45B 122M
Xencor XNCR:US $ 505.97M 81.6M
YTE INCY:US $ 3288.09M 169.42M